faCellitate

faCellitate is a private, early-revenue company providing innovative tools for 3D cell culture, a critical enabler for cell therapy and regenerative medicine research. Its core technology, BIOFLOAT™, is a defined, room-temperature-stable coating that modifies standard labware to prevent cell attachment, facilitating the easy and reproducible formation of complex cell aggregates like spheroids and organoids. The company's products are validated by top-tier research institutions and target the growing market for predictive in vitro models, positioning it as a key supplier in the preclinical research tools sector. Its business model is platform-based, selling coated consumables directly to research laboratories.

BIOFLOAT™: A synthetic, xeno-free, polymeric coating technology that creates an inert, cell-repellent surface on standard labware to enable easy and reproducible 3D spheroid and organoid formation. Features 'coat-and-keep' room-temperature stability and is modular, allowing functionalization with specific biomolecules (biotags).

faCellitate competes in the ultra-low attachment (ULA) plates and coatings market against giants like Corning, Thermo Fisher, and Greiner Bio-One, as well as specialists like InSphero. Its key differentiation is its fully synthetic, room-temperature-stable, and customizable coating, offering a defined alternative to animal-derived or less consistent competitor products.